AT335061B - Verfahren zur herstellung von neuen cephalosporinen - Google Patents

Verfahren zur herstellung von neuen cephalosporinen

Info

Publication number
AT335061B
AT335061B AT556074A AT556074A AT335061B AT 335061 B AT335061 B AT 335061B AT 556074 A AT556074 A AT 556074A AT 556074 A AT556074 A AT 556074A AT 335061 B AT335061 B AT 335061B
Authority
AT
Austria
Prior art keywords
producing new
cephalosporines
new cephalosporines
producing
new
Prior art date
Application number
AT556074A
Other languages
English (en)
Other versions
ATA556074A (de
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ATA556074A publication Critical patent/ATA556074A/de
Application granted granted Critical
Publication of AT335061B publication Critical patent/AT335061B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT556074A 1973-07-06 1974-07-05 Verfahren zur herstellung von neuen cephalosporinen AT335061B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3227373A GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins

Publications (2)

Publication Number Publication Date
ATA556074A ATA556074A (de) 1976-06-15
AT335061B true AT335061B (de) 1977-02-25

Family

ID=10336049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT556074A AT335061B (de) 1973-07-06 1974-07-05 Verfahren zur herstellung von neuen cephalosporinen

Country Status (16)

Country Link
US (1) US4007174A (de)
JP (1) JPS5069093A (de)
AT (1) AT335061B (de)
BE (1) BE817304A (de)
CA (1) CA1055016A (de)
CH (1) CH615436A5 (de)
DE (1) DE2432415A1 (de)
DK (1) DK360874A (de)
ES (1) ES428015A1 (de)
FR (1) FR2235696B1 (de)
GB (1) GB1472534A (de)
IE (1) IE39595B1 (de)
LU (1) LU70477A1 (de)
NL (1) NL7409179A (de)
SE (1) SE7408892L (de)
ZA (1) ZA744349B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
WO2005009364A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533178C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) * 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005062898A2 (en) * 2003-12-24 2005-07-14 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (de) * 1962-12-14 1969-06-16 Astra Ab
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) * 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics

Also Published As

Publication number Publication date
SE7408892L (de) 1975-01-07
FR2235696A1 (de) 1975-01-31
IE39595L (en) 1975-01-06
CH615436A5 (en) 1980-01-31
IE39595B1 (en) 1978-11-22
GB1472534A (en) 1977-05-04
BE817304A (fr) 1975-01-06
FR2235696B1 (de) 1976-12-24
AU7072374A (en) 1976-01-08
DE2432415A1 (de) 1975-01-30
ES428015A1 (es) 1976-07-16
DK360874A (de) 1975-03-03
LU70477A1 (de) 1976-05-31
US4007174A (en) 1977-02-08
ATA556074A (de) 1976-06-15
NL7409179A (nl) 1975-01-08
JPS5069093A (de) 1975-06-09
ZA744349B (en) 1975-07-30
CA1055016A (en) 1979-05-22

Similar Documents

Publication Publication Date Title
AT335419B (de) Verfahren zur herstellung von neuen 2-cyclohexen-1-on-derivaten
AT341119B (de) Verfahren zur herstellung von neuen prostanderivaten
AT335061B (de) Verfahren zur herstellung von neuen cephalosporinen
AT334529B (de) Verfahren zur herstellung von neuen cephalosporinen
AT326137B (de) Verfahren zur herstellung von neuen 3-phenyl-6-halogen-pyridanzinverbindungen
ATA1021774A (de) Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten
AT341689B (de) Verfahren zur herstellung von neuen octapeptiden
AT351180B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT347580B (de) Verfahren zur herstellung von neuen cephalosporinen
AT334533B (de) Verfahren zur herstellung von neuen cephalosporinen
AT335607B (de) Verfahren zur herstellung von neuen beta-lactamantibiotica
AT333952B (de) Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen
AT338240B (de) Verfahren zur herstellung von neuen phenoxyathylaminen
AT339296B (de) Verfahren zur herstellung von neuen xanthenderivaten
AT333956B (de) Verfahren zur herstellung von neuen cephalosporinen
ATA271875A (de) Verfahren zur herstellung von neuen cephalosporinen
AT330958B (de) Verfahren zur herstellung von neuen cephalosporinen
AT335060B (de) Verfahren zur herstellung von neuen cephalosporinen
ATA43774A (de) Verfahren zur herstellung von neuen cephalosporinen
AT339481B (de) Verfahren zur herstellung von neuen cephalosporinen
ATA874574A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT333958B (de) Verfahren zur herstellung von neuen cephalosporinantibiotica
AT342609B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT348164B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT348165B (de) Verfahren zur herstellung von neuen d- homosteroiden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee